Monday 27th November 2017
The Royal College of Physicians, London, UK

The 2017 Hatter Institute HORIZON conference is a one day medical education meeting which will bring together a notable faculty of cardiology and diabetes experts from UCL and beyond who will consider a new era in the management of type 2 diabetes, asking: is cardiovascular protection at long last a reality? 


Chairs

Professor Derek Yellon
Professor of Molecular & Cellular Cardiology, University College London;
Director of the Hatter Cardiovascular Institute at
UCL Hospitals & Medical School, London, UK
Dr Richard Horton
Editor-in-Chief
The Lancet
Professor John Cunningham
Professor of Nephrology, University College London Medical School
and The Royal Free Hospital;
Honorary Fellowship, Trinity Hall, University of Cambridge, UK

Programme
The full programme is HERE


CPD
The Hatter Cardiovascular Institute Horizons Series 2017: a new era in the management of type 2 diabetes: is cardiovascular protection at long last a reality? (code: 114424) has been approved for 6 credits.


Who should attend?

This meeting is ideal for:

    • Consultants
    • GPs
    • Nurses
    • Researchers and
    • Scientists

who any healthcare professionals who have an interest in the future shape and direction of Cardio-Diabetes research and treatment.


When & Where
Monday 27th November 2017
The Royal College of Physicians, London, UK
11 St Andrews Place,
London
NW1 4LE
Map here


Costs
The meeting costs will be underwritten by Pharmaceutical Industry supporters and the event is free of charge for healthcare professionals to attend. Places are strictly limited by room capacity.

Please click here if you would like to add the dates to your diary.


Express Your Interest 2018
If you are already registered and require pre-event assistance, please contact the ‘At the Limits’ Event Team: thechairs@horizonseries.org or phone +44 (0) 1491 419 800 during UK business hours 09:00 – 17:00.

If you wish to express your interest in the 2018 event please click here.


The Horizon 2017 meeting is supported by grants & sponsorship from the Pharmaceutical Industry.
As support agreements are reached, disclosure of the supporters is listed here.